Manulife (Manufacturers Life Insurance)
STLN

Manulife (Manufacturers Life Insurance)’s Starling Oncology STLN Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$111K Sell
20,530
-1,364
-6% -$5.73K ﹤0.01% 2720
2026
Q1 		$67.2K Buy
21,894
+63
+0.3% +$193 ﹤0.01% 2696
2025
Q4 		$77.7K Buy
21,831
+1,037
+5% +$3.85K ﹤0.01% 2757
2025
Q3 		$72.6K Sell
20,794
-97
-0.5% -$332 ﹤0.01% 2837
2025
Q2 		$42.8K Buy
+20,891
New +$52.2K ﹤0.01% 2899

Other funds holding STLN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $159M AUM 142.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s STLN Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Starling Oncology (STLN) stake by 6.2% in Q2 2026, selling an estimated $5.73K and leaving 20,530 shares worth $111K. The position accounts for ﹤0.01% of the portfolio, ranked #2720.

Manulife (Manufacturers Life Insurance) first reported a position in STLN in Q2 2025 and has held it in 5 quarters since. 119 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 20,530 shares of Starling Oncology worth $111K as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) sold 1,364 Starling Oncology shares in Q2 2026, an estimated $5.73K.
  • Starling Oncology made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #2720 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Starling Oncology in Q2 2025 and has held it in 5 quarters since.
  • 119 funds tracked by Wall St. Rank held Starling Oncology as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.